The Correlation of Hippocampal T2-Mapping with Neuropsychology Test in Patients with Alzheimer's Disease

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Luo, Zhuren ^a   Zhuang, Xiongjie ^a   Kumar, Dushyant ^b   Wu, Xiurong ^a   Yue, Cen ^a   Han, Chengkun ^a   Lv, Jiancheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; AGE; ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; BRAIN MAPPING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; SCORING SYSTEM; AGED; ANALYSIS OF VARIANCE; CHEMISTRY; IMAGE PROCESSING; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; SEX DIFFERENCE;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; NEUROPSYCHOLOGICAL TESTS; SEX FACTORS;

EID: 84884777832     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076203     Document Type: Article

References (49)

1. Giannakopoulos P, Hof PR, Giannakopoulos AS, Herrmann FR, Michel JP, et al. (1995) Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients. Arch Neurol 52: 1150-1159. doi:10.1001/archneur.1995.00540360028012. PubMed: 7492288.
2. Pearson RC, Esiri MM, Hiorns RW, Wilcock GK, Powell TP, (1985) Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc Natl Acad Sci U S A 82: 4531-4534. doi:10.1073/pnas.82.13.4531. PubMed: 3859874.
3. Braak H, Braak E, Bohl J, (1993) Staging of Alzheimer-related cortical destruction. Eur Neurol 33: 403-408. doi:10.1159/000116984. PubMed: 8307060.
4. Loeffler DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, et al. (1995) Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J Neurochem 65: 710-716. PubMed: 7616227.
5. Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ, (1992) Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res 31: 327-335. doi:10.1002/jnr.490310214. PubMed: 1573683.
6. Cornett CR, Markesbery WR, Ehmann WD, (1998) Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology 19: 339-346. PubMed: 9621340.
7. Dedman DJ, Treffry A, Candy JM, Taylor GA, Morris CM, et al. (1992) Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. Biochem J 287: 509-514. PubMed: 1445209.
8. Ehmann WD, Markesbery WR, Alauddin M, Hossain TI, Brubaker EH, (1986) Brain trace elements in Alzheimer's disease. Neurotoxicology 7: 195-206. PubMed: 3714121.
9. Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, et al. (2000) In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem 74: 270-279. PubMed: 10617129.
10. Collingwood JF, Mikhaylova A, Davidson M, Batich C, Streit WJ, et al. (2005) In situ characterization and mapping of iron compounds in Alzheimer's disease tissue. J Alzheimers Dis 7: 267-272. PubMed: 16131727.
11. Honda K, Casadesus G, Petersen RB, Perry G, Smith MA, (2004) Oxidative stress and redox-active iron in Alzheimer's disease. Ann N Y Acad Sci 1012: 179-182. doi:10.1196/annals.1306.015. PubMed: 15105265.
12. Deibel MA, Ehmann WD, Markesbery WR, (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci 143: 137-142. doi:10.1016/S0022-510X(96)00203-1. PubMed: 8981312.
13. Thompson CM, Markesbery WR, Ehmann WD, Mao YX, Vance DE, (1988) Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology 9: 1-7. PubMed: 3393299.
14. Doraiswamy PM, Finefrock AE, (2004) Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol 3: 431-434. doi:10.1016/S1474-4422(04)00809-9. PubMed: 15207800.
15. Zheng H, Weiner LM, Bar-Am O, Epsztejn S, Cabantchik ZI, et al. (2005) Design, synthesis, and evaluation of a novel bifunctional iron-chelator as a potential agent for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases. Bioorg Med Chem 13: 773-783. doi:10.1016/j.bmc.2004.10.037. PubMed: 15653345.
16. Liu G, Garrett MR, Men P, Zhu X, Perry G, et al. (2005) Nanoparticle and other metal chelation therapeutics in Alzheimer's disease. Biochim Biophys Acta 1741: 246-252. doi:10.1016/j.bbadis.2005.06.006. PubMed: 16051470.
17. Hasan KM, Walimuni IS, Kramer LA, Narayana PA, (2012) Human brain iron mapping using atlas-based T2 relaxometry. Magn Reson Med 67: 731-739. doi:10.1002/mrm.23054. PubMed: 21702065.
18. Brittenham GM, Badman DG, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Workshop (2003) Noninvasive measurement of iron: report of an NIDDK workshop. Blood 101: 15-19. doi:10.1182/blood-2002-06-1723. PubMed: 12393526.
19. Brownstein KR, Tarr CE, (1977) Spin-lattice relaxation in a system governed by diffusion. J Magn Reson 26: 17-24.
20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944. doi:10.1212/WNL.34.7.939. PubMed: 6610841.
21. Thomas LO, Boyko OB, Anthony DC, Burger PC, (1993) MR detection of brain iron. AJNR Am J Neuroradiol 14: 1043-1048. PubMed: 8237678.
22. Hallgren B, Sourander P, (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3: 41-51. doi:10.1111/j.1471-4159.1958.tb12607.x. PubMed: 13611557.
23. Gelman N, Gorell JM, Barker PB, Savage RM, Spickler EM, et al. (1999) MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 210: 759-767. PubMed: 10207479.
24. Novellino F, Cherubini A, Chiriaco C, Morelli M, Salsone M, et al. (2013) Brain iron deposition in essential tremor: A quantitative 3-tesla magnetic resonance imaging study. Mov Disord 28: 196-200. doi:10.1002/mds.25263. PubMed: 23238868.
25. Cherubini A, Péran P, Caltagirone C, Sabatini U, Spalletta G, (2009) Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI. NeuroImage 48: 29-36. doi:10.1016/j.neuroimage.2009.06.035. PubMed: 19540925.
26. Péran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, et al. (2010) Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 133: 3423-3433. doi:10.1093/brain/awq212. PubMed: 20736190.
27. Kolind SH, Mädler B, Fischer S, Li DK, MacKay AL, (2009) Myelin water imaging: Implementation and development at 3.0T and comparison to 1.5T measurements. Magn Reson Med 62: 106-115. doi:10.1002/mrm.21966. PubMed: 19353659.
28. LeVine SM, (1997) Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 760: 298-303. doi:10.1016/S0006-8993(97)00470-8. PubMed: 9237552.
29. Smith MA, Harris PL, Sayre LM, Perry G, (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A 94: 9866-9868. doi:10.1073/pnas.94.18.9866. PubMed: 9275217.
30. Haley AP, Knight-Scott J, Fuchs KL, Simnad VI, Manning CA, (2004) Shortening of hippocampal spin-spin relaxation time in probable Alzheimer's disease: a 1H magnetic resonance spectroscopy study. Neurosci Lett 362: 167-170. doi:10.1016/j.neulet.2004.01.031. PubMed: 15158006.
31. Schenck JF, Zimmerman EA, Li Z, Adak S, Saha A, et al. (2006) High-field magnetic resonance imaging of brain iron in Alzheimer disease. Top Magn Reson Imaging 17: 41-50. doi:10.1097/01.rmr.0000245455.59912.40. PubMed: 17179896.
32. House MJ, St Pierre TG, Foster JK, Martins RN, Clarnette R, (2006) Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss. AJNR Am J Neuroradiol 27: 430-439. PubMed: 16484425.
33. Campeau NG, Petersen RC, Felmlee JP, O'Brien PC, Jack CR Jr, (1997) Hippocampal transverse relaxation times in patients with Alzheimer disease. Radiology 205: 197-201. PubMed: 9314985.
34. Huesgen CT, Burger PC, Crain BJ, Johnson GA, (1993) In vitro MR microscopy of the hippocampus in Alzheimer's disease. Neurology 43: 145-152. doi:10.1212/WNL.43.1_Part_1.145. PubMed: 8423879.
35. Laakso MP, Partanen K, Soininen H, Lehtovirta M, Hallikainen M, et al. (1996) MR T2 relaxometry in Alzheimer's disease and age-associated memory impairment. Neurobiol Aging 17: 535-540. doi:10.1016/S0197-4580(96)00036-X. PubMed: 8832627.
36. Kirsch SJ, Jacobs RW, Butcher LL, Beatty J, (1992) Prolongation of magnetic resonance T2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease. Neurosci Lett 134: 187-190. doi:10.1016/0304-3940(92)90513-7. PubMed: 1589144.
37. Wang H, Yuan H, Shu L, Xie J, Zhang D, (2004) Prolongation of T2 relaxation times of hippocampus and amygdala in Alzheimer's disease. Neurosci Lett 363: 150-153. doi:10.1016/j.neulet.2004.03.061. PubMed: 15172104.
38. Pitkänen A, Laakso M, Kälviäinen R, Partanen K, Vainio P, et al. (1996) Severity of hippocampal atrophy correlates with the prolongation of MRI T2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease. Neurology 46: 1724-1730. doi:10.1212/WNL.46.6.1724. PubMed: 8649578.
39. Reinikainen KJ, Pitkänen A, Riekkinen PJ, (1989) 2', 3'-cyclic nucleotide-3'-phosphodiesterase activity as an index of myelin in the post-mortem brains of patients with Alzheimer's disease. Neurosci Lett 106: 229-232. doi:10.1016/0304-3940(89)90230-9. PubMed: 2555748.
40. Wang D, Zhang LH, Xu W, Du XX, Zhan YQ, et al. (2010) Iron and senile plaques deposition in transgenic mouse model of Alzheimer's disease and influence on MR T2 relaxation times. Chin J Neurol 43: 626-631.
41. Englund E, Brun A, Persson B, (1987) Correlations between histopathologic white matter changes and proton MR relaxation times in dementia. Alzheimer Dis Assoc Disord 1: 156-170. doi:10.1097/00002093-198701030-00008. PubMed: 3453747.
42. Englund E, Brun A, Alling C, (1998) White matter changes in dementia of Alzheimer's type: biochemical and neuropathological correlates. Brain 111: 1425-1439.
43. Sjöbeck M, Englund E, (2003) Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes. Neuropathol Appl Neurobiol 29: 159-169. doi:10.1046/j.1365-2990.2003.00456.x. PubMed: 12662323.
44. Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, et al. (2003) White matter structural integrity in healthy aging adults and patients with Alzheimer disease. Arch Neurol 60: 393-398. doi:10.1001/archneur.60.3.393. PubMed: 12633151.
45. Bartzokis G, (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25: 5-18. doi:10.1016/S0197-4580(04)80016-2. PubMed: 14675724.
46. Roher AE, Weiss N, Kokjohn TA, Kuo YM, Kalback W, et al. (2002) Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry 41: 11080-11090. doi:10.1021/bi026173d. PubMed: 12220172.
47. House MJ, St Pierre TG, Kowdley KV, Montine T, Connor J, et al. (2007) Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from Alzheimer's disease patients. Magn Reson Med 57: 172-180. doi:10.1002/mrm.21118. PubMed: 17191232.
48. Besson JA, Best PV, Skinner ER, (1992) Post-mortem proton magnetic resonance spectrometric measures of brain regions in patients with a pathological diagnosis of Alzheimer's disease and multi-infarct dementia. Br J Psychiatry 160: 187-190. doi:10.1192/bjp.160.2.187. PubMed: 1540758.
49. Breger RK, Rimm AA, Fischer ME, Papke RA, Haughton VM, (1989) T1 and T2 measurements on a 1.5-T commercial MR imager. Radiology 171: 273-276. PubMed: 2928538.